COVID-19 Impact on Blood Screening Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Blood Screening, including the following market information:
Major competitors identified in this market include Abbott Laboratories, Abbott, Apex Biotechnology Corp., Beckman Coulter (A Subsidiary of Danaher Corporation), Becton, Dickinson and Company, Biomrieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche, Grifols, Hem, etc.
Based on the Region:
- Global Blood Screening Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Blood Screening Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Blood Screening Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Blood Screening Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Major competitors identified in this market include Abbott Laboratories, Abbott, Apex Biotechnology Corp., Beckman Coulter (A Subsidiary of Danaher Corporation), Becton, Dickinson and Company, Biomrieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche, Grifols, Hem, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Reagent
- Instrument
- Blood Bank
- Hospital
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Blood Screening Industry
1.7 COVID-19 Impact: Blood Screening Market Trends
2 GLOBAL BLOOD SCREENING QUARTERLY MARKET SIZE ANALYSIS
2.1 Blood Screening Business Impact Assessment - COVID-19
2.1.1 Global Blood Screening Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Blood Screening Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Blood Screening Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Blood Screening Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Blood Screening Factory Price by Manufacturers
3.3 Location of Key Manufacturers Blood Screening Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Blood Screening Market
3.5 Key Manufacturers Blood Screening Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON BLOOD SCREENING SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Reagent
1.4.2 Instrument
4.2 By Type, Global Blood Screening Market Size, 2019-2021
4.2.1 By Type, Global Blood Screening Market Size by Type, 2020-2021
4.2.2 By Type, Global Blood Screening Price, 2020-2021
5 IMPACT OF COVID-19 ON BLOOD SCREENING SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Blood Bank
5.5.2 Hospital
5.2 By Application, Global Blood Screening Market Size, 2019-2021
5.2.1 By Application, Global Blood Screening Market Size by Application, 2019-2021
5.2.2 By Application, Global Blood Screening Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Business Overview
7.1.2 Abbott Laboratories Blood Screening Quarterly Production and Revenue, 2020
7.1.3 Abbott Laboratories Blood Screening Product Introduction
7.1.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.2 Abbott
7.2.1 Abbott Business Overview
7.2.2 Abbott Blood Screening Quarterly Production and Revenue, 2020
7.2.3 Abbott Blood Screening Product Introduction
7.2.4 Abbott Response to COVID-19 and Related Developments
7.3 Apex Biotechnology Corp.
7.3.1 Apex Biotechnology Corp. Business Overview
7.3.2 Apex Biotechnology Corp. Blood Screening Quarterly Production and Revenue, 2020
7.3.3 Apex Biotechnology Corp. Blood Screening Product Introduction
7.3.4 Apex Biotechnology Corp. Response to COVID-19 and Related Developments
7.4 Beckman Coulter (A Subsidiary of Danaher Corporation)
7.4.1 Beckman Coulter (A Subsidiary of Danaher Corporation) Business Overview
7.4.2 Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Quarterly Production and Revenue, 2020
7.4.3 Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Product Introduction
7.4.4 Beckman Coulter (A Subsidiary of Danaher Corporation) Response to COVID-19 and Related Developments
7.5 Becton, Dickinson and Company
7.5.1 Becton, Dickinson and Company Business Overview
7.5.2 Becton, Dickinson and Company Blood Screening Quarterly Production and Revenue, 2020
7.5.3 Becton, Dickinson and Company Blood Screening Product Introduction
7.5.4 Becton, Dickinson and Company Response to COVID-19 and Related Developments
7.6 Biomrieux
7.6.1 Biomrieux Business Overview
7.6.2 Biomrieux Blood Screening Quarterly Production and Revenue, 2020
7.6.3 Biomrieux Blood Screening Product Introduction
7.6.4 Biomrieux Response to COVID-19 and Related Developments
7.7 Bio-Rad Laboratories, Inc.
7.7.1 Bio-Rad Laboratories, Inc. Business Overview
7.7.2 Bio-Rad Laboratories, Inc. Blood Screening Quarterly Production and Revenue, 2020
7.7.3 Bio-Rad Laboratories, Inc. Blood Screening Product Introduction
7.7.4 Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
7.8 F. Hoffmann-La Roche
7.8.1 F. Hoffmann-La Roche Business Overview
7.8.2 F. Hoffmann-La Roche Blood Screening Quarterly Production and Revenue, 2020
7.8.3 F. Hoffmann-La Roche Blood Screening Product Introduction
7.8.4 F. Hoffmann-La Roche Response to COVID-19 and Related Developments
7.9 Grifols
7.9.1 Grifols Business Overview
7.9.2 Grifols Blood Screening Quarterly Production and Revenue, 2020
7.9.3 Grifols Blood Screening Product Introduction
7.9.4 Grifols Response to COVID-19 and Related Developments
7.10 Hem
7.10.1 Hem Business Overview
7.10.2 Hem Blood Screening Quarterly Production and Revenue, 2020
7.10.3 Hem Blood Screening Product Introduction
7.10.4 Hem Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Blood Screening Supply Chain Analysis
8.1.1 Blood Screening Supply Chain Analysis
8.1.2 Covid-19 Impact on Blood Screening Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Blood Screening Distribution Channels
8.2.2 Covid-19 Impact on Blood Screening Distribution Channels
8.2.3 Blood Screening Distributors
8.3 Blood Screening Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Blood Screening Industry
1.7 COVID-19 Impact: Blood Screening Market Trends
2 GLOBAL BLOOD SCREENING QUARTERLY MARKET SIZE ANALYSIS
2.1 Blood Screening Business Impact Assessment - COVID-19
2.1.1 Global Blood Screening Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Blood Screening Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Blood Screening Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Blood Screening Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Blood Screening Factory Price by Manufacturers
3.3 Location of Key Manufacturers Blood Screening Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Blood Screening Market
3.5 Key Manufacturers Blood Screening Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON BLOOD SCREENING SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Reagent
1.4.2 Instrument
4.2 By Type, Global Blood Screening Market Size, 2019-2021
4.2.1 By Type, Global Blood Screening Market Size by Type, 2020-2021
4.2.2 By Type, Global Blood Screening Price, 2020-2021
5 IMPACT OF COVID-19 ON BLOOD SCREENING SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Blood Bank
5.5.2 Hospital
5.2 By Application, Global Blood Screening Market Size, 2019-2021
5.2.1 By Application, Global Blood Screening Market Size by Application, 2019-2021
5.2.2 By Application, Global Blood Screening Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Business Overview
7.1.2 Abbott Laboratories Blood Screening Quarterly Production and Revenue, 2020
7.1.3 Abbott Laboratories Blood Screening Product Introduction
7.1.4 Abbott Laboratories Response to COVID-19 and Related Developments
7.2 Abbott
7.2.1 Abbott Business Overview
7.2.2 Abbott Blood Screening Quarterly Production and Revenue, 2020
7.2.3 Abbott Blood Screening Product Introduction
7.2.4 Abbott Response to COVID-19 and Related Developments
7.3 Apex Biotechnology Corp.
7.3.1 Apex Biotechnology Corp. Business Overview
7.3.2 Apex Biotechnology Corp. Blood Screening Quarterly Production and Revenue, 2020
7.3.3 Apex Biotechnology Corp. Blood Screening Product Introduction
7.3.4 Apex Biotechnology Corp. Response to COVID-19 and Related Developments
7.4 Beckman Coulter (A Subsidiary of Danaher Corporation)
7.4.1 Beckman Coulter (A Subsidiary of Danaher Corporation) Business Overview
7.4.2 Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Quarterly Production and Revenue, 2020
7.4.3 Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Product Introduction
7.4.4 Beckman Coulter (A Subsidiary of Danaher Corporation) Response to COVID-19 and Related Developments
7.5 Becton, Dickinson and Company
7.5.1 Becton, Dickinson and Company Business Overview
7.5.2 Becton, Dickinson and Company Blood Screening Quarterly Production and Revenue, 2020
7.5.3 Becton, Dickinson and Company Blood Screening Product Introduction
7.5.4 Becton, Dickinson and Company Response to COVID-19 and Related Developments
7.6 Biomrieux
7.6.1 Biomrieux Business Overview
7.6.2 Biomrieux Blood Screening Quarterly Production and Revenue, 2020
7.6.3 Biomrieux Blood Screening Product Introduction
7.6.4 Biomrieux Response to COVID-19 and Related Developments
7.7 Bio-Rad Laboratories, Inc.
7.7.1 Bio-Rad Laboratories, Inc. Business Overview
7.7.2 Bio-Rad Laboratories, Inc. Blood Screening Quarterly Production and Revenue, 2020
7.7.3 Bio-Rad Laboratories, Inc. Blood Screening Product Introduction
7.7.4 Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
7.8 F. Hoffmann-La Roche
7.8.1 F. Hoffmann-La Roche Business Overview
7.8.2 F. Hoffmann-La Roche Blood Screening Quarterly Production and Revenue, 2020
7.8.3 F. Hoffmann-La Roche Blood Screening Product Introduction
7.8.4 F. Hoffmann-La Roche Response to COVID-19 and Related Developments
7.9 Grifols
7.9.1 Grifols Business Overview
7.9.2 Grifols Blood Screening Quarterly Production and Revenue, 2020
7.9.3 Grifols Blood Screening Product Introduction
7.9.4 Grifols Response to COVID-19 and Related Developments
7.10 Hem
7.10.1 Hem Business Overview
7.10.2 Hem Blood Screening Quarterly Production and Revenue, 2020
7.10.3 Hem Blood Screening Product Introduction
7.10.4 Hem Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Blood Screening Supply Chain Analysis
8.1.1 Blood Screening Supply Chain Analysis
8.1.2 Covid-19 Impact on Blood Screening Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Blood Screening Distribution Channels
8.2.2 Covid-19 Impact on Blood Screening Distribution Channels
8.2.3 Blood Screening Distributors
8.3 Blood Screening Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Blood Screening Assessment
Table 9. COVID-19 Impact: Blood Screening Market Trends
Table 10. COVID-19 Impact Global Blood Screening Market Size
Table 11. Global Blood Screening Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Blood Screening Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Blood Screening Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Blood Screening Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Blood Screening Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Blood Screening Market Growth Drivers
Table 17. Global Blood Screening Market Restraints
Table 18. Global Blood Screening Market Opportunities
Table 19. Global Blood Screening Market Challenges
Table 20. Key Manufacturers Blood Screening Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Blood Screening Market Size, 2019 (K Units) & (US$ Million)
Table 22. Blood Screening Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Blood Screening Manufacturing Plants
Table 24. Key Manufacturers Blood Screening Market Served
Table 25. Date of Key Manufacturers Enter into Blood Screening Market
Table 26. Key Manufacturers Blood Screening Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Blood Screening Market Size by Type, 2020, (US$ Million)
Table 29. Global Blood Screening Market Size by Type, 2020 (K Units)
Table 30. Global Blood Screening Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Blood Screening Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Blood Screening Market Size by Application, 2020-2021 (K Units)
Table 33. Global Blood Screening Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Blood Screening Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Blood Screening Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Blood Screening Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Blood Screening Market Size, 2019-2021 (K Units)
Table 38. US Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Blood Screening Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Blood Screening Market Size, 2019-2021 (K Units)
Table 43. Germany Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Blood Screening Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Blood Screening Market Size, 2019-2021 (K Units)
Table 50. China Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott Laboratories Blood Screening Product
Table 60. Abbott Laboratories Response to COVID-19 and Related Developments
Table 61. Abbott Business Overview
Table 62. Abbott Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Abbott Blood Screening Product
Table 64. Abbott Response to COVID-19 and Related Developments
Table 65. Apex Biotechnology Corp. Business Overview
Table 66. Apex Biotechnology Corp. Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Apex Biotechnology Corp. Blood Screening Product
Table 68. Apex Biotechnology Corp. Response to COVID-19 and Related Developments
Table 69. Beckman Coulter (A Subsidiary of Danaher Corporation) Business Overview
Table 70. Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Product
Table 72. Beckman Coulter (A Subsidiary of Danaher Corporation) Response to COVID-19 and Related Developments
Table 73. Becton, Dickinson and Company Business Overview
Table 74. Becton, Dickinson and Company Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Becton, Dickinson and Company Blood Screening Product
Table 76. Becton, Dickinson and Company Response to COVID-19 and Related Developments
Table 77. Biomrieux Business Overview
Table 78. Biomrieux Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Biomrieux Blood Screening Product
Table 80. Biomrieux Response to COVID-19 and Related Developments
Table 81. Bio-Rad Laboratories, Inc. Business Overview
Table 82. Bio-Rad Laboratories, Inc. Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Bio-Rad Laboratories, Inc. Blood Screening Product
Table 84. Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
Table 85. F. Hoffmann-La Roche Business Overview
Table 86. F. Hoffmann-La Roche Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. F. Hoffmann-La Roche Blood Screening Product
Table 88. F. Hoffmann-La Roche Response to COVID-19 and Related Developments
Table 89. Grifols Business Overview
Table 90. Grifols Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Grifols Blood Screening Product
Table 92. Grifols Response to COVID-19 and Related Developments
Table 93. Hem Business Overview
Table 94. Hem Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Hem Blood Screening Product
Table 96. Hem Response to COVID-19 and Related Developments
Table 97. Blood Screening Distributors List
Table 98. Blood Screening Customers List
Table 99. Covid-19 Impact on Blood Screening Customers
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Blood Screening Assessment
Table 9. COVID-19 Impact: Blood Screening Market Trends
Table 10. COVID-19 Impact Global Blood Screening Market Size
Table 11. Global Blood Screening Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Blood Screening Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Blood Screening Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Blood Screening Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Blood Screening Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Blood Screening Market Growth Drivers
Table 17. Global Blood Screening Market Restraints
Table 18. Global Blood Screening Market Opportunities
Table 19. Global Blood Screening Market Challenges
Table 20. Key Manufacturers Blood Screening Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Blood Screening Market Size, 2019 (K Units) & (US$ Million)
Table 22. Blood Screening Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Blood Screening Manufacturing Plants
Table 24. Key Manufacturers Blood Screening Market Served
Table 25. Date of Key Manufacturers Enter into Blood Screening Market
Table 26. Key Manufacturers Blood Screening Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Blood Screening Market Size by Type, 2020, (US$ Million)
Table 29. Global Blood Screening Market Size by Type, 2020 (K Units)
Table 30. Global Blood Screening Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Blood Screening Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Blood Screening Market Size by Application, 2020-2021 (K Units)
Table 33. Global Blood Screening Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Blood Screening Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Blood Screening Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Blood Screening Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Blood Screening Market Size, 2019-2021 (K Units)
Table 38. US Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Blood Screening Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Blood Screening Market Size, 2019-2021 (K Units)
Table 43. Germany Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Blood Screening Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Blood Screening Market Size, 2019-2021 (K Units)
Table 50. China Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Blood Screening Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Abbott Laboratories Business Overview
Table 58. Abbott Laboratories Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott Laboratories Blood Screening Product
Table 60. Abbott Laboratories Response to COVID-19 and Related Developments
Table 61. Abbott Business Overview
Table 62. Abbott Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Abbott Blood Screening Product
Table 64. Abbott Response to COVID-19 and Related Developments
Table 65. Apex Biotechnology Corp. Business Overview
Table 66. Apex Biotechnology Corp. Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Apex Biotechnology Corp. Blood Screening Product
Table 68. Apex Biotechnology Corp. Response to COVID-19 and Related Developments
Table 69. Beckman Coulter (A Subsidiary of Danaher Corporation) Business Overview
Table 70. Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Beckman Coulter (A Subsidiary of Danaher Corporation) Blood Screening Product
Table 72. Beckman Coulter (A Subsidiary of Danaher Corporation) Response to COVID-19 and Related Developments
Table 73. Becton, Dickinson and Company Business Overview
Table 74. Becton, Dickinson and Company Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Becton, Dickinson and Company Blood Screening Product
Table 76. Becton, Dickinson and Company Response to COVID-19 and Related Developments
Table 77. Biomrieux Business Overview
Table 78. Biomrieux Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Biomrieux Blood Screening Product
Table 80. Biomrieux Response to COVID-19 and Related Developments
Table 81. Bio-Rad Laboratories, Inc. Business Overview
Table 82. Bio-Rad Laboratories, Inc. Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Bio-Rad Laboratories, Inc. Blood Screening Product
Table 84. Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
Table 85. F. Hoffmann-La Roche Business Overview
Table 86. F. Hoffmann-La Roche Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. F. Hoffmann-La Roche Blood Screening Product
Table 88. F. Hoffmann-La Roche Response to COVID-19 and Related Developments
Table 89. Grifols Business Overview
Table 90. Grifols Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Grifols Blood Screening Product
Table 92. Grifols Response to COVID-19 and Related Developments
Table 93. Hem Business Overview
Table 94. Hem Blood Screening Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Hem Blood Screening Product
Table 96. Hem Response to COVID-19 and Related Developments
Table 97. Blood Screening Distributors List
Table 98. Blood Screening Customers List
Table 99. Covid-19 Impact on Blood Screening Customers
LIST OF FIGURES
Figure 1. Blood Screening Product Picture
Figure 2. Blood Screening Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Blood Screening Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Blood Screening Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Blood Screening Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Blood Screening Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Blood Screening Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Blood Screening Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Blood Screening Market Size Market Share, 2019-2021
Figure 1. Blood Screening Product Picture
Figure 2. Blood Screening Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Blood Screening Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Blood Screening Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Blood Screening Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Blood Screening Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Blood Screening Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Blood Screening Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Blood Screening Market Size Market Share, 2019-2021
